NASDAQ:ALLR

Allarity Therapeutics Stock Predictions

etoro logo Buy ALLR
*Your capital is at risk
$1.58
-0.110 (-6.51%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

ALLR Prediction Chart

ALLR Predictions History

Latest community submissions for ALLR.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 16, 2024 $2.35 -96.08% $1.68 X 59.98% 0
Apr 16, 2024 $2.22 -96.30% $1.68 X 67.85% 0
JS JS Pro
Apr 16, 2024 $2.03 -96.62% $1.68 X 79.17% 0
Jul 6, 2023 $7.79 -99.84% $3.81 V 0.00% 1
Jul 6, 2023 $7.97 -99.84% $3.81 V 0.00% 1
Jul 6, 2023 Bullish $3.81 X 0
Apr 20, 2023 $0.88 -99.99% $0.602 X 53.92% 0
Apr 20, 2023 $0.795 -99.99% $0.602 X 67.92% 0
Apr 20, 2023 Bearish $0.602 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ALLR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ALLARITY THERAPEUTICS, INC.
Allarity Therapeutics
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microt...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE